Navigation Links
Lev Pharmaceuticals Reports Positive Results in Pivotal Phase III,Trial for Hereditary Angioedema

ary angioedema should contact the Company directly at 212-682-3096, or visit the Company's website at http://www.levpharma.com. Additional information on HAE can be obtained from the U.S. Hereditary Angioedema Association at http://www.haea.org.

Legal notice to investors: Certain matters discussed in this news release are "forward-looking statements." These forward-looking statements, which apply only on the date of this release, generally can be identified by the use of forward-looking terminology such as "may," "will," "expects," "intends," "estimates," "anticipates," "believes," "continues" or words of similar import. Similarly, statements that describe Lev's future plans, objectives or goals are also forward-looking statements, which generally involve known and unknown risks, uncertainties and other facts that may cause the actual results, performance or achievements of Lev to be materially different from those expressed or implied by such forward-looking statements. Such factors may include the following: uncertainties associated with product development: the risk that Lev will not obtain approval to market its products, the risk that Lev's products will not gain market acceptance, the risks associated with dependence upon key personnel, the need for additional financing and other risks described in Lev's periodic reports filed with the Securities and Exchange Commission.

CONTACT: Joshua Schein, Ph.D., Chief Executive Officer of LevPharmaceuticals, Inc., +1-212-682-3096, ; orinvestors, Lilian Stern, Stern Investor Relations, +1-212-362-1200, for LevPharmaceuticals, Inc.; or media, Jeff Siegel of Monarch Communications,+1-516-569-4271, for Lev Pharmaceuticals, Inc. jschein@levpharma.com

Web site: http://
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
2. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
4. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
5. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
6. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
7. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
8. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
9. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
10. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
11. Arisaph Pharmaceuticals Announces Results of its Potent Smart DPP-4 Inhibitor, ARI-2243, at the ADA

Post Your Comments:
(Date:11/23/2009)...v.23/PRNewswire-FirstCall/--CeptionTherapeutics,In...lon,Inc.(Nasdaq: CEPH )todayannouncedresultsfromaP...asatreatmentforpediatriceosinophilicesophagitis(Eo...-primaryendpointsofchangesinesophagealeosinophille...thatpatientstreatedwithCINQUILshowedastatistically...
(Date:11/23/2009)...wire/--AdvancedSterilizationProducts(ASP),aleading...dtodaytheacquisitionbyitsFrenchaffiliate,ApsisS.A....tivedisinfectionprocessesandtechnologiestopreventh...werenotdisclosed. ,, GlosterEuropedesignsandmar...rovidesdisinfectionofpatientenvironmentssuchashosp...
(Date:11/20/2009)...wswire/ -- The United States Court of Appeals for...t ruling yesterday, approving a settlement in the ...eutical litigation against AstraZeneca Pharmaceuti...cgi-bin/prnh/20080317/AQM144LOGO ) ,, The rulin...purchased the pharmaceutical giant,s prostate canc...
Breaking Medicine Technology:Ception Therapeutics and Cephalon Provide Initial Results of a Phase IIb/III Study of CINQUIL in Pediatric Eosinophilic Esophagitis 2Ception Therapeutics and Cephalon Provide Initial Results of a Phase IIb/III Study of CINQUIL in Pediatric Eosinophilic Esophagitis 3Ception Therapeutics and Cephalon Provide Initial Results of a Phase IIb/III Study of CINQUIL in Pediatric Eosinophilic Esophagitis 4ASP Announces Acquisition of Gloster Europe to Help Reduce Infections in Healthcare Facilities 2U.S. Court of Appeals Upholds AstraZeneca AWP Settlement 2U.S. Court of Appeals Upholds AstraZeneca AWP Settlement 3For Chest Pain in the ER CT Angiography May Be Best 61756 1American Academy of Cosmetic Surgery Opposes Cosmetic Surgery Tax 61754 1American Academy of Cosmetic Surgery Opposes Cosmetic Surgery Tax 61754 2Artemisinin Resistance Threatens Efforts to Control Malaria 61752 1Artemisinin Resistance Threatens Efforts to Control Malaria 61752 2Artemisinin Resistance Threatens Efforts to Control Malaria 61752 3Artemisinin Resistance Threatens Efforts to Control Malaria 61752 4
...itions and Methods, ROCKVILLE, Md., June 11 Entr...maceutical company developing,therapeutics for the...day,announced the issuance of U.S. Patent No. 7,37...2). The patent grants EntreMed composition-of-matt...ion through 2025 for analogs,of 2ME2 in oncology a...
...June 11 , - Data Published in the British Journal...ative Impact on Overall Survival or Tumour,Progres...randomised, controlled,studies in 2,301 cancer pat...(R) (epoetin beta) has no negative impact on survi...clots, when used within its approved,indications (...
Other Medicine Technology:EntreMed Receives New Patent for 2-Methoxyestradiol Analogs 2EntreMed Receives New Patent for 2-Methoxyestradiol Analogs 3New Meta-Analysis Confirms Safety Profile for NeoRecormon in Treating Anaemia in Cancer Patients 2
(Date:11/23/2009)...sin Washington D.C. , NewYorkCity , LosAng...icGrowthandRevitalization ,, WASHINGTON,Nov.23...dingproviderofdialysisservices,todaywaslaudedbyD.C...illioninvestmentinIndustrialBankaspartofaninitiati...ita,sinvestmentinWashington,D.C.ispartofthedialysi...
(Date:11/23/2009)...swire/--Hazelden,theinternationallyrenownednonprof...shipteamforitsnewrecoverycenterinNaples,Florida.Ha...ateMarch2010,andwillinitiallyprovideaddictiontreat...ndoutpatientservices. ,, MichaelDemask,Ph.D.,wi...ples,withBrendaIliff,M.A.,L.A.D.C.,asclinicaldirec...
(Date:11/23/2009)...sin Washington D.C. , NewYork , N.Y. , L...ndedtoSpurEconomicGrowthandRevitalization ,, W...enation,sleadingproviderofdialysisservices,todayan...createjobsandspurrevitalizationinminoritycommuniti...yandminority-ownedbanks.DaVitahasdonated$5milliont...
(Date:11/23/2009)...e"reform"isamoraloutrage ,, WASHINGTON,Nov.23...vedforwardtobeginthedebateontheirhealthcare"reform...ggrassrootssenioradvocacygroup,iscallingonallofAme...vecutstoMedicare.RetireSafePresidentThairPhillipss...xes,abortion,andimmigration,whilethesimple,uncompl...
(Date:11/23/2009)...SupportsFutureLeadersinSTEMFields ,, Scholars... ceS c holars.org ,, WASHINGTON,Nov...untusin.Withourcommunity,foundation,andcorporatepa...te,"saidAdolphP.Falcon,SeniorVicePresidentoftheNat...eHousemeetingtodaywherePresidentObamaannouncedthec...
Breaking Medicine News(10 mins):Health News:DaVita Launches Minority Bank Initiative with $1 Million Investment in Industrial Bank of Washington, D.C. to Support Underserved Communities 2Health News:DaVita Launches Minority Bank Initiative with $1 Million Investment in Industrial Bank of Washington, D.C. to Support Underserved Communities 3Health News:DaVita Launches Minority Bank Initiative with $1 Million Investment in Industrial Bank of Washington, D.C. to Support Underserved Communities 4Health News:Hazelden Names Leadership Team for New Recovery Center in Naples, Florida 2Health News:DaVita Launches Minority Bank Initiative with $5 Million Investment in Underserved Communities Across the Country 2Health News:DaVita Launches Minority Bank Initiative with $5 Million Investment in Underserved Communities Across the Country 3Health News:RetireSafe Calls on Seniors to Grab their Bullhorns to Save Medicare from Rationed Care 2Health News:Alliance Joins President Obama at White House in Commitment to Science, Technology, Engineering, and Math (STEM) Education 2
...N ANTONIO, Texas, Aug. 10 Organic Alliance,Inc. (... release this week,declaring that Dr. Gail Morriso...ice of Academic Programs at the University of Penn...n holds. The,retraction is not for any negative re...
...munity can fade after first injection, so second s...althDay News) -- When the vaccine against chickenp...dical experts hoped it would be a one-shot deal, w...hat the protection from a single immunization fade...
... The U.S. Military has sel...gital Imaging provider. iCRco,s radiography system...diagnoses for our troops injured in battle. , ...o,s radiography systems will ensure highly portabl...
...LAHOMA CITY, Aug. 8 PD-Rx Pharmaceuticals,Inc., a...day announced that,it has completed a repurchase o...e outstanding Preferred Shares of Class "A" 13.25%...e,stock call represents PD-Rx,s position to improv...
...RACUSE, N.Y., Aug. 8 "The passage of federal,legi...ellness policies -- a,response by Congress to the ...ked back upon as the launching pad for the school ...ing by,identifying schools as playing a key role i...
...normal beating a marker for those most likely to d... (HealthDay News) -- Abnormal heart rate turbulenc... sudden death in patients with congestive heart fa... and heart failure progression, as well as sudden ...
Other Medicine News:Health News:Organic Alliance Officially Retracts Announcement on Addition of Dr. Gail Morrison to the Medical Advisory Board 2Health News:Chickenpox Protection: Get That Booster 2Health News:Chickenpox Protection: Get That Booster 3Health News:US Military Chooses American Made iCRco Digital Radiography Systems 2Health News:PD-Rx Completes Call for Preferred A Stock 2Health News:As Kids Head Back to School, National Advocacy Group Issues Report on Progress of School Wellness 2Health News:As Kids Head Back to School, National Advocacy Group Issues Report on Progress of School Wellness 3Health News:As Kids Head Back to School, National Advocacy Group Issues Report on Progress of School Wellness 4
...dle. Divides nucleus for phacoemulsification. Nucl...of any hardness can be pre-chopped with pre-chop f... nuclear fragments is rapid. Risk of rupturing pos...tened ultra sound time and minimal movement of pha...
Appasamy Phaco Choppper
Steinert Blade
Appasamy Blade
Medicine Products: